A comparison of the effects of risperidone, raclopride, and ritanserin on intravenous self-administration of d-amphetamine. (Q48016836)

7 February 2018

title

A comparison of the effects of risperidone, raclopride, and ritanserin on intravenous self-administration of d-amphetamine. (English)

1 reference

7 February 2018

1 reference

Fletcher PJ

1

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

7 February 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

7 February 2018

volume

60

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

55-60

1 reference

7 February 2018

Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Fluoxetine reduces intravenous cocaine self-administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Cocaine self-administration is increased by both D1 and D2 dopamine antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Parameters of self-administration of cocaine in rats under a progressive-ratio schedule.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Mixed D2/5-HT2A antagonism of amphetamine-induced facilitation of brain stimulation reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Serotonergic regulation of associative learning

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

The effects of putative 5-hydroxytryptamine receptor active agents on D-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Increased self-administration of d-amphetamine by rats pretreated with metergoline

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Destruction of dopaminergic nerve terminals in nucleus accumbens: Effect on d-amphetamine self-administration

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Increased self-administration of d-amphetamine after destruction of 5-hydroxytryptaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Potentiation of the effects of raclopride on sucrose consumption by the 5-HT2 antagonist ritanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Self-administration of d-amphetamine by rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Dietary tryptophan supplements attenuate amphetamine self-administration in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Dopaminergic substrates of amphetamine-induced place preference conditioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

An open clinical and biochemical study of ritanserin in acute patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

Brain dopamine and reward

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

5-HT2 receptor involvement in conditioned olfactory learning in the neonate rat pup.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900559-5

7 January 2021

10.1016/S0091-3057(97)00559-5

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

9610924

1 reference

7 February 2018